1. by Alex Aleshin, and Peter L. Greenberg
Molecular pathophysiology of the myelodysplastic syndromes: insights for targeted therapy
by Alex Aleshin, and Peter L. Greenberg
BloodAdv
Volume 2(20):
October 23, 2018
© 2018 by The American Society of Hematology

2. Alex Aleshin, and Peter L. Greenberg Blood Adv 2018;2:2787-2797
© 2018 by The American Society of Hematology

3. Molecular targets and therapeutics in MDS
Molecular targets and therapeutics in MDS. The heterogeneity of molecular abnormalities extant within the MDS spectrum of disorders, involving a variety of somatically mutated genes and biologic functions, is demonstrated along with therapeutic agents in clinical trials focused on targeting these lesions.
Molecular targets and therapeutics in MDS. The heterogeneity of molecular abnormalities extant within the MDS spectrum of disorders, involving a variety of somatically mutated genes and biologic functions, is demonstrated along with therapeutic agents in clinical trials focused on targeting these lesions.
Alex Aleshin, and Peter L. Greenberg Blood Adv 2018;2:
© 2018 by The American Society of Hematology